share_log

热景生物(688068.SH):拟收购关联公司持有的开景基因100%股权

Hot View Biotech (688068.SH): Proposes to acquire 100% of Kaijing Gene's shares held by an affiliated company

Gelonghui Finance ·  Apr 15 05:26

On April 15, Gelonghui Biotech (688068.SH) announced that in order to integrate the in-vitro diagnosis business of the company and its affiliated companies, the company plans to acquire 100% of the shares of Beijing Kaijing Gene Technology Co., Ltd. (“Kaijing Gene”) held by the affiliated company Beijing Shunjing Biomedical Technology Co., Ltd. (“Shunjing Pharmaceutical”). The transfer price for this transaction was 11 million yuan, all of which were paid in cash.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment